News

Indian Company Gains Right to Copy Generic Cancer Drug

India has authorized a domestic pharmaceutical company to manufacture an expensive anti-cancer drug developed by Bayer Corporation. The move undermines Bayer’s patent on the drug, but has been praised by activists because it will make the drug cheaper and more widely available.

Under the ruling by the controller of patents in Mumbai, the Indian drug company, Natco Pharma, can make a generic copy of Nexavar and sell it for a fraction of the price charged by Bayer.

The patented drug is used to treat liver and kidney cancer. The Indian company will sell it for about $175 for 120 tablets compared to approximately $5,500 charged by Bayer. It will pay a royalty to Bayer of six percent. 

The move effectively ends Bayer’s monopoly on the drug. Authorities used a rule under which they can grant a “compulsory license” if a drug is not available at a “reasonably affordable price.” This is the first time India has applied the rule.

The Indian patent controller says the drug was clearly unaffordable to most of the country because very few patients had used it.

Bayer had argued that the price should reflect the development cost and not just the public’s buying power. The company has said it is disappointed with the decision and will evaluate its options to defend its intellectual property rights in India.

The decision has been welcomed by Doctors Without Borders, which campaigns for affordable drugs in poor countries. Leena Menghaney, the group’s manager in New Delhi, says there has to be a balance between intellectual property rights and the right of patients to have access to new and expensive medicines.

“What it shows with the Indian system that it has an independent mechanism," Menghaney. "If there is a problem with the pricing of a patented medicine, there is a redressal in the system. We have not seen this kind of mechanism work in other developing countries and would encourage South Africa and other countries like Thailand to adopt the system where a competitor can come forward to supply a more affordable generic version.”

Pharmaceutical analysts say the ruling could set a precedent for other expensive medicines to be licensed to local companies.

They say that it will be a setback for the multinational drug industry in India. The world’s big drug companies argue that they rely on intellectual property protection to fund the high cost of research. The industry has been pushing for stronger patent protections and rules to clamp down on the Indian generics industry.

In the past decade, India has been providing cheap, life-saving medicines for patients in poor countries who cannot afford drugs at Western prices to treat diseases like HIV and malaria. Most of these are generic copies of drugs protected by patents in the United States and Europe.

This forum has been closed.
Comment Sorting
Comments
     
by: Paddy O
March 13, 2012 12:58 PM
Bayer would have been better off just offering it for cheaper in India. Certainly the research costs are fully recouped in the west. With losing control of the patent, they will now have to face the possibility of unauthorized manufacturers exporting it (either illicitly or not) and thus, wiping out even more potential profits. I'm surprised such a gross failure in risk management would occur at a major German company like this.

by: Sharman
March 13, 2012 12:42 PM
Very few people may know that it is Bayer company that sold Methyl Parathion and Ediphenphose deadly toxic crop pesticides in India till 2005 while those were banned in Europe and US many many years ago due to its harmful effects. Every year people got intoxicated and dying in India and Bayer kept on harvesting the highest profits out of these products.

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Calais School Offers Another Face of Europe’s Migrant Crisisi
X
Lisa Bryant
September 02, 2015 6:19 PM
Europe is facing mounting criticism over how it’s handling its biggest migration crisis since World War II. But not all Europeans believe building walls or passing repressive policies are the answer. A school for migrants in the French port city of Calais, is opening doors and building bonds across nationalities. VOA's Lisa Bryant reports.
Video

Video Calais School Offers Another Face of Europe’s Migrant Crisis

Europe is facing mounting criticism over how it’s handling its biggest migration crisis since World War II. But not all Europeans believe building walls or passing repressive policies are the answer. A school for migrants in the French port city of Calais, is opening doors and building bonds across nationalities. VOA's Lisa Bryant reports.
Video

Video Russia-Japan Relations Cool as Putin Visits China for WWII Anniversary

Russian President Vladimir Putin is in Beijing for commemorations of the 70th anniversary of China's WWII victory over Japan. Putin is expected to visit Japan later this year, but tensions between Tokyo and Moscow over islands disputed since the war, and sanctions over Ukraine, could pour cold water on the plan. VOA's Daniel Schearf reports.
Video

Video Kurdish Fighters on IS Frontline Ready for Offensive

Finger on the trigger, the Kurdish Peshmerga soldier stared across the dust at a village taken over by Islamic State extremists. The Kurdistan’s Khazir frontline, just 45 minutes from the Islamic State stronghold of Mosul. And at this point, the militants were less than two kilometers away. VOA's Sharon Behn reports.
Video

Video Yemen ‘on Brink of Disaster’ as Medical Shortages Soar

Aid agencies warn Yemen is on the brink of humanitarian disaster – with up to half a million children facing severe malnutrition, and hospitals running out of basic medicines. There are fears Yemen's civil war could escalate as the coalition led by Saudi Arabia tries to drive back Houthi rebels, who seized control of much of the country earlier this year. Henry Ridgwell reports.
Video

Video Apps Helping Kenyan Businesses Stay Ahead of Counterfeiters

Counterfeit goods in Kenya cost the government as much as $1 billion each year in lost tax revenues. The fake goods also hurt entrepreneurs who find it hard to carve out a niche in the market and retain customers. But as Lenny Ruvaga reports from Nairobi, information technology is being used to try to beat the problem.
Video

Video Nobel Prize Winner Malala Talks to VOA

Nobel Peace Prize winner Malala Yousafzai met with VOA's Deewa service in Washington Sunday to talk about women’s rights and unveil a trailer for her new documentary. VOA's Katherine Gypson has more.
Video

Video War, Drought Threaten Iraq's Marshlands

Iraq's southern wetlands are in crisis. These areas are the spawning ground for Gulf fisheries, a resting place for migrating wildfowl, and source of livelihood for fishermen and herders. Faith Lapidus has more.
Video

Video Colombians Flee Venezuela as Border Crisis Escalates

Hundreds of Colombians have fled Venezuela since last week, amid an escalating border crisis between the two countries. Last week, Venezuelan President Nicolas Maduro ordered the closure of a key border crossing after smugglers injured three Venezuelan soldiers and a civilian. The president also ordered the deportation of Colombians who are in Venezuela illegally. Zlatica Hoke reports.
Video

Video Rebuilding New Orleans' Music Scene

Ten years after Hurricane Katrina inundated New Orleans, threatening to wash away its vibrant musical heritage along with its neighborhoods, the beat goes on. As Bronwyn Benito and Faith Lapidus report, a Musicians' Village is preserving the city's unique sound.
Video

Video In Russia, Auto Industry in Tailspin

Industry insiders say country relies too heavily on imports as inflation cuts too many consumers out of the market. Daniel Schearf has more from Moscow.
Video

Video Scientist Calls Use of Fetal Tissue in Medical Research Essential

An anti-abortion group responsible for secret recordings of workers at a women's health care organization claims the workers shown are offering baby parts for sale, a charge the organization strongly denies. While the selling of fetal tissue is against the law in the United States, abortion and the use of donated fetal tissue for medical research are both legal. VOA’s Julie Taboh reports.
Video

Video Next to Iran, Climate at Forefront of Obama Agenda

President Barack Obama this week announced new initiatives aimed at making it easier for Americans to access renewable energy sources such as solar and wind. Obama is not slowing down when it comes to pushing through climate change measures, an issue he says is the greatest threat to the country’s national security. VOA correspondent Aru Pande has more from the White House.
Video

Video Arctic Draws International Competition for Oil

A new geopolitical “Great Game” is underway in earth’s northernmost region, the Arctic, where Russia has claimed a large area for resource development and President Barack Obama recently approved Shell Oil Company’s test-drilling project in an area under U.S. control. Greg Flakus reports.
Video

Video Philippine Maritime Police: Chinese Fishermen a Threat to Country’s Security

China and the Philippines both claim maritime rights in the South China Sea.  That includes the right to fish in those waters. Jason Strother reports on how the Philippines is catching Chinese nationals it says are illegal poachers. He has the story from Palawan province.
Video

Video China's Spratly Island Building Said to Light Up the Night 'Like A City'

Southeast Asian countries claim China has illegally seized territory in the Spratly islands. It is especially a concern for a Philippine mayor who says Beijing is occupying parts of his municipality. Jason Strother reports from the capital of Palawan province, Puerto Princesa.

VOA Blogs